Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DBF4 pseudogene 1 (DBF4P1) is a non-functional genomic sequence that resembles the active DBF4 gene but does not encode a protein or participate directly in cell cycle regulation or DNA replication[4]. Pseudogenes like DBF4P1 may arise from duplication or retrotransposition events and often lack promoter activity or have disruptive mutations, rendering them transcriptionally incompetent. The DBF4 gene encodes a zinc finger protein that regulates the CDC7 kinase, playing a central role in DNA replication and cell division, but DBF4P1 itself does not participate in these processes[1][2][3][4]. If the intended target is the active DBF4 gene rather than the pseudogene, structured information should be provided for **DBF4-CDC7 kinase regulatory subunit (DBF4)**, not DBF4P1. If instead you specifically need pseudogene/repetitive sequence information, DBF4P1 is not considered a canonical molecular target for therapeutics or clinical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DBF4 pseudogene 1 (DBF4P1).